Phosphorylation of SREBP-1 also has clinical implications as we have recently reported a rare heterozygous mutation in a patient with severe dyslipidemia hampering specifically phosphorylation of Erk- and JNK-MAPK specific S117 in SREBP-1a [48]. This evidence concerns the gene SREBF1 and metabolic syndrome.